Post by Novo Nordisk

Novo Nordisk’s haemophilia A product demonstrated positive results in long-term safety and efficacy in the phase 3 FRONTIER extension study as presented at ISTH 2026. Read more here: https://lnkd.in/d6Xe8wD #PRESS